Trident Texofab Ltd — Others, 26-05-2025: Corp Action

Trident Texofab Limited has announced a board meeting outcome approving the conversion of 96,287 warrants into an equal number of equity shares at Rs. 70 each (including a Rs. 60 premium), following receipt of the balance payment of Rs. 52.50 per warrant. These shares were allotted to non-promoter public category investors on a preferential basis. Post-conversion, the company’s paid-up share capital increased to Rs. 14.06 Cr, comprising 1.40 crore equity shares of Rs. 10 each. Approximately 18.44 lakh warrants remain outstanding for conversion under the same terms, offering potential equity dilution. This move strengthens equity base and liquidity, relevant for shareholder value.